Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression
- 1 August 1994
- journal article
- Published by Elsevier in Clinical Radiology
- Vol. 49 (8) , 559-562
- https://doi.org/10.1016/s0009-9260(05)82937-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancerBritish Journal of Cancer, 1992
- C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasiaCancer, 1991
- The long term prognostic significance of c-erbB-2 in primary breast cancerBritish Journal of Cancer, 1991
- c-erbB-2 oncoprotein expression in primary and advanced breast cancerBritish Journal of Cancer, 1991
- Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situBreast Cancer Research and Treatment, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysisThe Journal of Pathology, 1990
- Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situThe Lancet, 1990
- An immunohistochemical study of the presence of c‐erbB‐2 protein in Paget's disease of the nippleHistopathology, 1989